The growing problem of co-treatment with opioids and benzodiazepines A powerful example of potentially dangerous low value care

  • Karaca-Mandic Associate Professor P
  • Meara Professor E
  • Morden Associate Professor N
ISSN: 0959-8138
N/ACitations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Abstract

Since 1999, the US has witnessed a fourfold increase in deaths from overdose involving prescription opioids, 1 a fact widely known by US residents. That benzodiazepines are present in over 30% of overdoses involving prescription opioids is less well known. 2 Using claims based data from 315 428 privately insured individuals in the US with at least one filled prescription for an opioid in 2001-13, Sun and colleagues (doi:10.1136/bmj.j760) examined the prevalence of a hazardous prescription combination. 3 The risk of combining opioids and benzodiazepines has long been understood; both drug classes can be sedating, suppress respiratory efforts, impair thought, slow response time, and increase falls. 2 Sun and colleagues found an alarming rise in this prescribing practice in their study population, from 9% in 2001 to 17% in 2013. They report a significantly increased risk of overdose among patients receiving both drug types concurrently, documenting one type of harm associated with this unsound and growing clinical practice.

Cite

CITATION STYLE

APA

Karaca-Mandic Associate Professor, P., Meara Professor, E., & Morden Associate Professor, N. E. (2017). The growing problem of co-treatment with opioids and benzodiazepines A powerful example of potentially dangerous low value care, 1224, 2–3.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free